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Abstract
Background: Ephrins and their related receptors have been implicated in some developmental events. We have
demonstrated that ephrin-B2 (EFNB2) could play a role in knee joint pathology associated with osteoarthritis (OA).
Here, we delineate the in vivo role of EFNB2 in musculoskeletal growth, development, and in OA using a cartilage-
specific EFNB2 knockout (EFNB2Col2KO) mouse model.
Methods: EFNB2Col2KO was generated with Col2a1-Cre transgenic mice. The skeletal development was evaluated
using macroscopy, immunohistochemistry, histomorphometry, radiology, densitometry, and micro-computed
tomography. Analyses were performed at P0 (birth) and on postnatal days P15, P21, and on 8-week- and 1-year-old
mice.
Results: EFNB2Col2KO mice exhibited significant reduction in size, weight, length, and in long bones. At P0, the
growth plates of EFNB2Col2KO mice displayed increased type X collagen, disorganized hyphertrophic zone, and
decreased mineralization. At P15, mutant mice demonstrated a significant reduction in VEGF and TRAP at the
chondro-osseous junction and a delay in the secondary ossification, including a decrease in bone volume and
trabecular thickness. At P21 and 8 weeks old, EFNB2Col2KO mice exhibited reduced bone mineral density in the
total skeleton, femur and spine. One-year-old EFNB2Col2KO mice demonstrated OA phenotypic features in both the
knee and hip. By P15, 27 % of the EFNB2Col2KO mice developed a hip locomotor phenotype, which further
experiments demonstrated reflected the neurological midline abnormality involving the corticospinal tract.
Conclusion: This in vivo study demonstrated, for the first time, that EFNB2 is essential for normal long bone
growth and development and its absence leads to a knee and hip OA phenotype in aged mice.
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Background
Erythropoietin-producing hepatocellular receptors (Eph)
are the largest family of cell surface receptor tyrosine ki-
nases, representing about 25 % of known receptor tyro-
sine kinases [1, 2]. There are a total of 15 Ephs classified
by sequence homology into subfamilies A and B, but not
all are expressed in a given species [3, 4]. Ephs bind to
their ephrin (EFN) ligands, which are also cell surface
molecules [2]. There are nine EFNs divided into A and B
subfamilies. Generally, type A receptors bind preferen-
tially to EFNA, and type B receptors (EphB1-4 and B6)
to EFNB, but there are a few exceptions.
The Eph/EFN system was first demonstrated to be es-
sential in the development of neuronal connections, cir-
cuit plasticity and repair. Subsequently, their presence
and functions have been shown in many organs and
tissues in which they were shown to play a role in a
number of biological processes [5]. The receptor/ligand
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EphB4/EFNB2 has been shown to be implicated in bone
maintenance and repair [6–8]. However, the role of
EFNB2 in skeletal growth and development has never
been investigated, likely due to the fact that germ-line
mutation of EFNB2 in mice leads to embryonic lethality
in homozygous nulls [9, 10].
As both EphB4/EFNB2 are present in the growth plate
[8], in vivo EphB4 enhances the process of endochondral
ossification bone repair [11], and their presence and activity
in adult articular chondrocytes have been demonstrated
[12], we further investigated the in vivo role of EFNB2 in
skeletal growth and development. To this end, we gener-
ated a cartilage-specific EFNB2 knockout (KO) mouse
model, using Col2a1-Cre transgenic mice (EFNB2Col2KO),
as chondrocytes are crucial to bone development.
Moreover, our group previously demonstrated that
EFNB2 treatment of human osteoarthritic (OA) chon-
drocytes positively impacts the abnormal metabolism of
these cells [12]. Thus, the present mouse model, in
addition to permitting a better understanding of the role
of EFNB2 in endochondral bone development, will en-
able further exploration of the long-term effect of this
deletion on knee and hip cartilage in order to substanti-




Mice were maintained in accordance with the Canadian
Council on Animal Care (CCAC) and protocols reviewed
and approved by the Institutional Animal Care Committee
(CIPA) of the University of Montreal Hospital Centre
(CHUM). All mice were kept in a 12-h light/dark cycle.
Food and water were available ad libitum.
We have previously reported on the generation of
EFNB2 floxed (EFNB2fl/fl) mice [13]. They were back-
crossed with C57BL/6 for 10 generations and then mated
with transgenic mice expressing Cre recombinanse driven
by type II collagen promoter (Col2a1-Cre) in the C57BL/6
background [14] to obtain mutant mice with a cartilage-
specific deletion of EFNB2 (EFNB2Col2KO).
The generation and characterization of EFNB2Col2KO
cartilage conditional mice were as follows. C57BL/6-
EFNB2fl/fl mice were mated with C57BL/6 Col2-Cre trans-
genic mice to generate offspring bearing Col2-Cre and a
floxed allele in their germline (genotype: EFNB2fl/+, Cre).
These mice were backcrossed to homozygote floxed mice
in the following cross: EFNB2fl/+, Cre X EFNB2fl/fl, to gen-
erate mice with both alleles inactivated in chondrocytes
(genotype: EFNB2fl/fl, Cre), and EFNB2fl/fl mice without
Cre transgene were used as control mice. Such breeding
results in wild type, and heterozygote and homozygote
knockout (EFNB2Col2KO) mice. The study used the
homozygote EFNB2Col2KO and the EFNB2fl/fl as controls.
The offspring of the breeding animals were genotyped
using PCR analysis. The EFNB2Col2KO cartilage condi-
tional mice were born at the expected Mendelian
frequencies.
The transgenic mouse genotype was determined by
PCR analyses of genomic DNA isolated from ear biop-
sies as previously described [15, 16]. The EFNB2Col2KO




GAG-3′ and reverse 5′-GAGTGAACGAACCTGGTC
GAAATCAGTGCG-3′ for Cre recombinase; and forward
5′-AGATACCACGCCAGGAGAGCAAAT-3′ and reverse
5′-GCGCACGGAGTTGGGTCTCG-3′ for EFNB2 exon 1
deletion. Schematic representation of the EFNB2 knockout
construct and primer design are illustrated in Fig. 1a.
The presence of the Cre transgene in postnatal day
zero (P0) heterozygous and homozygous knockout mice
and its absence in wild type mice were detected by the
EFNB2 floxed band at 552 base pairs (bp), the wild type
at 450 bp, Cre at 700 bp, and the EFNB2 exon 1 deletion
at 550 bp (Fig. 1b). EFNB2fl/fl mice without the Cre
transgene were used as control mice. Homozygous mice
were compared to control at birth (P0) and on postnatal
days P15 and P21, and at 8 weeks and 1 year old.
Skeletal staining
Skeletal staining was processed in newborn mouse ca-
davers as described [17].
Radiographic, bone mineral density and morphometric
determinations
High resolution full body radiographic images were ob-
tained using a Kubtec XPERT 80 Digital Cabinet X-ray
System with a geometric magnification of × 1 and a reso-
lution of 5 μm (KUB Technologies Inc., Milford, CT,
USA). The mouse radiographs were obtained in the ven-
trodorsal projection with the limbs in abduction (frog-
legged position) and a standard ventrodorsal projection
with the limbs extended.
The bone mineral density (BMD) was determined
using a Lunar PixiMUS 1.46 (GE Lunar Corporation,
Madison, WI, USA). The morphometric analyses, in-
cluding the bone length and hip bone measurements,
were performed directly on the acquired images using a
calibrated program of the BIOQUANT OSTEO II
Image Analysis Software (BIOQUANT Image Analysis
Corporation, Nashville, TN, USA).
Other analyses included mouse weight and length at
P0, P15 and P21, and long bone measurements of the
tibia, femur and humerus at P0 and P15. These mea-
surements were performed directly on freshly dissected
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bones using digital calipers (model 2071 M; Mitutoyo
Corporation, Kawasaki, Japan).
Micro-computed tomography (μCT)
The left femora of 8-week-old mice were dissected free
of tissue, fixed as above and the distal metaphysis
scanned with a SKYSCAN 1176 in vivo μCT instrument
as described [15]. For the trabecular bone, 100 recon-
structed grayscale images were selected from immedi-
ately below the tibial and femoral growth plate, and a
3D analysis was used to calculate morphometric parame-
ters, including the bone volume (% bone volume/total
volume), trabecular thickness (μm), trabecular number
(l/mm) and trabecular separation (mm) at the same
threshold with the 3D-Creator software supplied with
the instrument.
Pelvic and hip acetabular evaluations
Mice at 8 weeks and 1 year old were evaluated for hip
dysplasia from the acquired μCT images by measuring
the acetabular rim length (ARL, mm), the dorsal acetab-
ular rim angle (DARA, angle degrees) and the acetabular
angle (AA, angle degrees) [18]. Values were manually ac-
quired on selected 2D μCT images by two independent
observers who were blinded to group allocation. The
ARL and the DARA of the right and left acetabula were
measured and averaged.
Histological, histochemical and immunohistochemical
analysis
The dissected right long bones were fixed in 4 % para-
formaldehyde for 16 h at 4 °C, decalcified in RDO Rapid
Decalcifier (Apex Engineering, Plainfield, IL, USA), and
embedded in paraffin, as described [15]. Deparaffinized
sections (5 μm) were stained with Safranin O/fast green
(Sigma-Aldrich, Oakville, ON, Canada) and assessed by
the BIOQUANT OSTEO II Image Analysis Software.
Briefly, a region of 500 μm under the growth plate was
selected and the total area was measured. In the same
region, the mineralized cartilage matrix (in red) was
Fig. 1 Genetically modified mice harboring a cartilage-specific deletion of ephrin-B2 (EFNB2) were generated using the Cre Lox methodology.
a Schematic representation of the EFNB2 knockout construct and primer design for the LoxP insertion in the EFNB2 gene (α-β) and EFNB2 exon 1
deletion (γ-β). b Representative genotyping that detects LoxP insertion in EFNB2 (552 base pairs (bp)), the presence of Cre transgene (700 bp)
and EFNB2 exon 1 deletion (550 bp) in heterozygous (n = 8) and homozygous knockout (KO) (n = 8) mice at postnatal day zero (P0) (birth) and
their absence in wild type (n = 8) mice assessed by PCR. MW molecular weight, KO knockout c Representative EFNB2 immunohistological staining
of the tibial growth plate at P15 (n = 4) counterstained with methyl green, and of tibial cartilage and subchondral bone at 8 weeks old (n = 4)
counterstained with hematoxylin and eosin. Immunohistological original magnification × 250 and insets × 400. Dotted-line boxes indicate the location
of the insets; scale bar 100 μm; arrows indicate positive-stained cells
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selected by the color intensity, the area measured, and
the ratio calculated.
Immunohistochemical analysis was performed on
5-μm paraffin sections, decalcified in 10 % ethylenedi-
amine tetraacetic acid (EDTA) for 14 days at 4 °C.
Briefly, sections were pretreated with 0.25 units/ml of
protease-free chondroitinase ABC in phosphate-buffered
saline (PBS) (Sigma-Aldrich, St. Louis, MO, USA) for
60 minutes at 37 °C. The specimens were incubated for
18 h at 4 °C with the following primary polyclonal anti-
bodies; rabbit anti-EFNB2 (1:50 dilution; Santa Cruz
Biotechnology, Dallas, TX, USA), rabbit anti-type II col-
lagen (1:30 dilution; EMD Millipore, Billerica, MA,
USA), mouse anti-proliferating cell nuclear antigen
(PCNA) (1:500 dilution; Abcam, Cambridge, MA, USA),
rabbit anti-vascular endothelial growth factor (VEGF)
(1:1500 dilution; Abcam) and rabbit anti-type X collagen
(1:100 dilution; provided by Dr E. Lee, Shriners Hospital
for Children, McGill University Hospital Centre, Montreal,
QC, Canada) [19]. Each slide was washed three times in
PBS (pH 7.4) and incubated with a secondary biotinyl-
ated antibody (anti-mouse, or anti-rabbit when appro-
priate) (Vector Laboratories Inc., Burlingame, CA,
USA), then processed using the Vectastain ABC kit
(Vector Laboratories) following the manufacturer’s in-
structions. The color was developed with 3,3’-diamino-
benzidine (DAB) containing hydrogen peroxide, and
slides were counterstained with methyl green.
Control procedures were performed according to the
same experimental protocol as follows: 1) omission of the
primary antibody and 2) substitution of the primary anti-
body with a nonspecific immunoglobulin from the same
host as the primary antibody (Santa Cruz Biotechnology).
Tartrate resistant acid phosphatase (TRAP) detection
was performed on paraffin sections, decalcified in 10 %
EDTA for 14 days at 4 °C. Sections were stained for en-
zyme activity and processed as described [20] and coun-
terstaining was performed with 0.4 % methyl green.
Negative staining was performed without substrate and
for all antibodies IgG controls displayed only back-
ground staining.
For the calcium deposition, freshly dissected left-side
long bones were fixed as above and embedded in glyc-
idyl methacrylate (GMA) plastic. Sections (2 μm) were
stained using the von Kossa method with 5 % silver ni-
trate for 30 minutes under ultraviolet light, and with
0.2 % toluidine blue to determine trabecular bone thick-
ness and bone volume. Histomorphometric data were
obtained using BIOQUANT OSTEO II Image Analysis
software.
To determine the number of TRAP-, VEGF- and type
X collagen-positive cells the chondro-osseous junction
area comprising the hypertrophic chondrocyte zone and
the cartilage bone junction as the upper and lower limits
was evaluated. Hence, for type X collagen, the area ana-
lyzed comprised a box of 300 × 100 μm in the hyper-
trophic chondrocyte zone close to the chondro-osseous
junction. The staining intensity of the total hypertrophic
zone was assessed on one section/specimen using a Leitz
Diaplan microscope (Leica Microsystems) connected to
BIOQUANT OSTEO II Image Analysis software [15].
Knee and hip cartilage evaluation
At one year old, the knee and hip joints were evaluated.
Sagittal sections (5 μm) from the mid-medial tibiofe-
moral joint were stained with Safranin O/fast green as
described [15]. Cartilage was assessed using the Osteo-
arthritis Research Society International (OARSI) scoring
system (knee) [21] and the modified Mankin system
(hip) [22]. For the synovial membrane, histomorpho-
metric quantitative analysis of the anterior synovial
membrane thickness was performed as described [16].
Images were captured at × 63 with a Leitz Diaplan
microscope coupled to a personal computer, and his-
tomorphometric data determined with BIOQUANT
OSTEO II Image Analysis Software; data are expressed as
μm. The anterior synovial membrane lining hyperplasia
was graded on a scale of 0–2, where 0 = absence, 1 =
hyperplasia of lining <50 % of the surface, and 2 = hyper-
plasia of lining >50 % of the surface, as described [23].
For both the cartilage and the synovial membrane, two
independent observers graded the severity of the tissue,
blinded to group allocation. Three sections were made
from each block, each slide was examined, and the final
score was a consensus between the two observations.
Tracing of the corticospinal tract
Surgical procedures and tracer injections
Surgical procedures and tracer injections were per-
formed on 6-week-old EFNB2Col2KO and control mice
anesthetized with a mixture of ketamine (70 mg/kg IP,
Ketalar; Pfizer, New York, NY, USA) and xylazine (3 mg/
kg IP; Sigma-Aldrich). Mice were placed in a stereotaxic
frame and transitioned to an inhalation anesthetic, iso-
flurane (approximately 2 %) in 100 % oxygen, delivered
via a custom-made facial mask as described [24]. After
the EFNB2Col2KO and control mice were anesthetized,
two small holes were made in the skull bone overlying
the left primary motor cortex, based on stereotaxic coor-
dinates (0.0, +1 mm anteroposterior, +1.5 mm mediolat-
eral to the bregma). In each hole, 1 μl of the anterograde
tracer biotinylated dextran amine (BDA; molecular
weight (MW) 10,000, 5 % in saline solution; Invitrogen)
was pressure injected with a Hamilton syringe and a
microsyringe pump controller (Harvard Apparatus,
Holliston, MA, USA). Tracer (1 μl) was injected in three
boluses at different depths to create a column that la-
beled all layers of the gray matter. First, 500 nl was
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injected at a depth of 2,500 μm from the top of the skull.
After a 2-minute rest period to favor the absorption of
the tracer by the tissue, a second bolus of 300 nl was
injected at 2,000 μm, again followed by a 2-minute rest
period. A third bolus of 200 nl was injected at 1,500 μm,
followed by a 5-minute rest period. Following injections
into the two holes, mice received buprenorphine hydro-
chloride (0.05 mg/ml IP, Temgesic) and their recovery
was monitored during a period of 2 h post surgery. They
were then returned to their home cage and given access
to food and water ad libitum. The mice were sacrificed
14 days after the injections of BDA. They were transcar-
dially perfused with 0.1 M PBS, followed by 4 % parafor-
maldehyde in 0.1 M PBS. The cervical spinal cords were
dissected and post fixed (20 % sucrose, 4 % paraformal-
dehyde solution in 0.1 M PBS for 2 h; 20 % sucrose, 2 %
dimethyl sulfoxide (DMSO) in 0.1 M PBS for 24 h; and
20 % sucrose for 48 h or until the tissues sank). The
cervical cord specimens (C4–C7) were quickly frozen at
–55 °C with methyl butane, embedded with optimum cut-
ting temperature compound (OCT, Tissue-Tek, Sakura
Finetek USA Inc., Torrance, CA, USA) and frozen at
–80 °C until sectioning. Transverse sections between C4
and C7 were cut with a cryostat (20 μm thickness). One
out of three sections was stained for BDA and used to
quantify the number of synaptic boutons.
Tissue processing
Tissue processing, in which the BDA staining was re-
vealed, was carried out according to the protocol of
Dancause et al. [25]. In brief, after sectioning, the tis-
sues were rinsed in cold 0.05 M potassium phosphate
buffer in saline solution (KPBS), treated with 0.4 %
Triton X-100 in 0.05 M KPBS and rinsed again in
0.05 M KPBS. They were then incubated overnight in
avidin-biotin (ABC) solution (two drops of solution A
and B per 5 ml of 0.05 KPBS; Vectastain Elite ABC
kit; Vector Laboratories, Burlingame, CA, USA). The
following day, following four rinses with 0.1 M KPBS,
the tissue was incubated in fresh 0.05 % DAB
0.015 % H2O2 in KPBS solution for 5–10 minutes.
After three additional rinses in 0.1 M KPBS, the sec-
tions were mounted on subbed slides and dried over-
night. DAB staining was intensified the following day.
Sections were dehydrated in ascending alcohol solu-
tions, transferred to xylene, rehydrated and incubated
in a 1.42 % AgNO3 solution for 1 h at 56 °C. They
were then passed through H2O (15 minutes), 0.2 %
HAuCl4 (10 minutes), 5 % Na2S2O3 (5 minutes) and
H2O (15 minutes). Finally, they were dehydrated again
followed by xylene and coverslipped the next day.
Other sections were either Nissl stained with Cresyl
violet to reveal spinal cord architecture (1/3) or kept
for future staining (1/3).
Image capture and quantitative analysis of BDA
Image capture and quantitative analysis of BDA was per-
formed as described [26]. In brief, the tissue was exam-
ined using a BX51 light microscope (Olympus, Tokyo,
Japan). Photographs were digitally captured using an
MBF CX9000 digital camera (MicroBrightField, Colches-
ter, VT, USA) with a resolution of 1600 × 1200 active
pixels and images imported to Adobe Photoshop CS5. A
neuroanatomical reconstruction system, consisting of a
computer-interfaced motorized stage mounted on a
microscope and associated software (Neurolucida;
MicroBrightField), was used to reconstruct sections
stained for BDA and to quantify the number of labeled
boutons at the C4–C7 levels. The most rostral section of
the block to be reconstructed was randomly chosen.
Then, one section out of every six BDA-stained sections
was reconstructed up to a total of ten sections. A vari-
cosity was considered to be a terminal bouton if it ap-
peared as a small, darkly labeled sphere contacting a
small fiber as described [26]. To quantify the number of
labeled boutons within each hemisphere of the spinal
cord, we examined the tissue using a grid pattern (100 ×
100 μm) overlaid on the section image. If at least two
synaptic boutons were located within a square of the
grid, a marker was placed in the center of the square.
Following inspection of the entire gray matter, the num-
bers of positive squares in each hemisphere were
compared.
Statistical analysis
Values are expressed as mean ± standard error of the
mean (SEM). Statistical analysis was performed using
the Mann–Whitney U test (GraphPad Prism software,
GraphPad, San Diego, CA, USA).
Results
Characterization of EFNB2Col2KO cartilage conditional
mice
The genotyping demonstrated the presence of the Cre
transgene in P0 heterozygous and homozygous knockout
mice and its absence in wild type mice (Fig. 1b). To
confirm the cartilage specific deletion, immunohisto-
chemical analysis using a specific EFNB2 antibody was
performed on the tibiae at P15 and at 8 weeks old.
EFNB2 was present in the cartilage of the control
(EFNB2fl/fl) and absent in the EFNB2Col2KO (Fig. 1c). Of
note, EFNB2 was present in the subchondral bone of
both the EFNB2fl/fl and EFNB2Col2KO mice (Fig. 1c).
Reduction in growth of EFNB2Col2KO mice
In newborn litters EFNB2Col2KO were smaller in size
compared to control mice (Fig. 2a). The delayed pattern
was observed in both genders but only data on male ani-
mals are presented in this article.
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Skeletal staining confirmed the reduced growth in the
homozygote EFNB2Col2KO mice compared to controls
at birth, and there was less skeletal staining in some re-
gions of the limbs of mutant mice than in the control
mice (Fig. 2a).
Morphometric analysis at P0, P15 and P21 showed that
the EFNB2Col2KO mice displayed a significant reduction
in body weight and length (Fig. 2b, c) when compared
with control mice. In addition, on measurement of indi-
vidual long bones at P0 and P15 there was a significant re-
duction in the long bone length (tibia, femur and
humerus) in the EFNB2Col2KO mice (Fig. 2d). At P21,
8 weeks and 1 year, the EFNB2Col2KO mice had signifi-
cantly smaller tibiae (P ≤0.03, P ≤0.01, and P ≤0.02, re-
spectively) and femora (P ≤0.03, P ≤0.03, and P ≤0.04)
compared with their controls.
Impaired angiogenesis and delayed cartilage resorption
in EFNB2Col2KO mice
As bone length is determined in part by the activity of
the growth plate during endochondral bone formation,
we further examined the growth plate morphology in
the EFNB2Col2KO mice. At P0, EFNB2Col2KO mice had
abnormalities at the growth plates of appendicular bones
(tibia, femur and humerus); there was a disorganized
hypertrophic cartilage zone with no difference in the re-
serve or proliferating zones.
Type II collagen is the principal collagen laid down by
proliferating, non-hypertrophic chondrocytes, whereas
type X collagen production is restricted to hypertrophic
cells in the epiphyseal cartilage. There were no differ-
ences in type II collagen (Fig. 3a, b) or the proliferation
marker, PCNA (data not shown), implying that early
stages of chondrocyte development were not affected by
the lack of EFNB2. However, type X collagen immuno-
staining displayed disorganized hypertrophic chondrocyte
columns (Fig. 3c-f) with increased staining (P <0.03) ac-
companied by a decrease in mineralized cartilage matrix
(P <0.007) (Fig. 3g-j) at the chondro-osseus junction,
which was also observed at P15 (P <0.03). In addition, P15
EFNB2Col2KO mice had a delay at the secondary center of
ossification (Fig. 3k, l) and significantly decreased VEGF
staining (Fig. 4a-c). The disturbed vascularization was as-
sociated with alterations in bone mineralization; the
percentage of bone volume/tissue volume and the tra-
becular thickness were also significantly reduced in the
EFNB2Col2KO mice compared to controls (Fig. 4d-f).
The terminal stage of hypertrophic chondrocyte de-
velopment is associated with invasion and resorption
of the calcified cartilage core. Given the delay in cal-
cification in the EFNB2Col2KO mice, we further inves-
tigated whether the lack of EFNB2 disturbed the
cartilage resorption process. The recruitment of and
invasion by TRAP-positive cells was significantly
Fig. 2 Macroscopy and morphological assessments of male ephrin-B2 (EFNB2)fl/fl and EFNB2Col2knockout (KO) cartilage conditional mice. a Representative
mascroscopic and histochemical results of EFNB2fl/fl (n = 6) and EFNB2Col2KO cartilage conditional (n = 6) mice at postnatal day zero (P0) (birth) showing
that the latter displayed reduced growth and skeletal development. Arrow indicates thinner stained region in the EFNB2Col2KO. Histograms show body
weight (b) and length (c) of EFNB2fl/fl and EFNB2Col2KO cartilage conditional mice at P0 (n = 8 and n = 9, respectively), P15 (n = 10 and
n = 8) and P21 (n = 13 and n = 11). d Morphometric analysis of long bone length of EFNB2fl/fl and EFNB2Col2KO cartilage conditional mice at P0 and
P15 (n = 8–13). Data are expressed as mean ± standard error of the mean and P values were determined by Mann–Whitney U test
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reduced in the EFNB2Col2KO mice compared to con-
trols (Fig. 4g-i).
Postnatal bone abnormalities in EFNB2Col2KO mice
Macroscopic and radiographic assessments at P21
showed reduced body size of EFNB2Col2KO mice
(Fig. 5a). Although no bone deformities were found in
the EFNB2Col2KO mice, osteopenia was observed in the
long bones (Fig. 5a). BMD analysis (Fig. 5b) showed that
EFNB2Col2KO mice had a significant reduction in the
BMD of the whole body, femoral head, and lumbar ver-
tebrae L4 and L5 at P21 and 8 weeks. At 1 year, al-
though BMD values were lower for each of the bones
studied, only for the femoral head BMD was statistically
significant.
μCT of the femur and tibia in the 8-week-old
EFNB2Col2KO mice showed a statistically significant re-
duction in the mineralized tissue (about 35 %, as evaluated
by the % bone volume/tissue volume) (Fig. 5c, d). Tra-
becular number and thickness in the proximal tibia were
also significantly decreased with an increase in trabecular
separation compared to control (Fig. 5d). Similar differ-
ences were observed in the distal femur with the excep-
tion of trabecular number (Fig. 5c). Histological sections
of the proximal tibia confirmed μCT data revealing thin-
ner trabeculae and an increase in the trabecular separation
(Fig. 5e). This decrease in mineralized tissue in the
EFNB2Col2KO could be the result of improper cartilage
matrix degradation caused by EFNB2 deficiency in late
hypertrophic chondrocytes.
Osteoarthritis (OA) phenotypic features in aged
EFNB2Col2KO mice
One-year-old EFNB2Col2KO mice demonstrated OA
phenotypic features associated with cartilage degener-
ation in both the knee and hip (Fig. 6). Radiologically,
EFNB2Col2KO mice exhibited a collapse of the joint with
decreased joint space (Fig. 6a, b). Histological analysis of
both the knee (medial tibia and condyle) and the prox-
imal femoral condyle showed that EFNB2Col2KO mice
Fig. 3 Immunohistochemical localization of type II collagen, type X collagen and Safranin O in epiphyseal cartilage. Representative
immunohistological sections of ephrin-B2 (EFNB2)fl/fl (n = 7) and EFNB2Col2knockout (KO) cartilage conditional (n = 7) mice at postnatal day zero
(P0) (birth) for type II collagen (a-b), type X collagen (c-f) and Safranin O (g-l) of the entire epiphyseal cartilage. e, f Higher magnification of c and
d. i, j Higher magnification of g and h. The secondary center of ossification at P15 is indicated by white arrows (k and l). a-f Slides were counterstained
with methyl green. Original magnification × 250 (a-d, g, h, k, l) and × 400 (e, f, i, j). Scale bars at 100 μm (a, e, k)
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had increased cartilage degradation with a loss of
Safranin O, reduced cellularity and thinning of the cartil-
age (Fig. 6c-i). As synovial membrane also demonstrated
alterations during the OA process, we further assessed
the effects of cartilage-specific EFNB2 deletion on this
tissue in 1-year-old mice. The synovial thickness was sig-
nificantly greater in the knee in the EFNB2Col2KO mice
(43.4 μm± 5.6) than in the control mice (113.7 μm±
27.2) (P ≤0.02) and in the hip (86.9 μm± 5.9 compared
to 143.3 μm± 18.5, respectively) (P ≤0.03). There were
no significant differences in the synovial lining cells be-
tween EFNB2Col2KO and the control mice.
Some EFNB2Col2KO mice exhibit a locomotor phenotype
related to an abnormal corticospinal tract
A surprising feature of the EFNB2Col2KO mice was a
locomotor phenotype observed in about 27 % of this
mouse population, which appeared as soon as the mice
started to walk at 2–3 weeks of age. It consisted of a lack
of unilateral hip motor control yielding a simultaneous
movement of the right and left limbs, resulting in a hop-
ping gait (Fig. 7), unlike the alternate step gait displayed
by control mice. Additional movie files show this in
more detail (see Additional file 1 and Additional file 2).
The EFNB2Col2KO long bone developmental abnor-
malities could not account for the observed locomotor
phenotype. However, the EFNB2Col2KO mice had a sig-
nificantly (P ≤0.01) smaller pelvic bone at 8 weeks com-
pared to controls, but not at 1 year (data not shown).
We then further investigated the possibility of abnormal
development of the hip joint. μCT of the EFNB2Col2KO
proximal femoral head of the acetabular rim angle, ace-
tabular angle and acetabular rim length of 8-week-old
and 1-year-old mice did not differ from controls (Fig. 8),
suggesting that the EFNB2Col2KO mice did not have any
hip joint abnormalities that could explain the locomotor
phenotype.
The above finding indicates that a cause other than
the hip development is responsible for the EFNB2Col2KO
locomotor phenotype. A search of the literature revealed
that this locomotor phenotype resembles those reported
for mice lacking the EFNB3 ligand or its receptor EphA4
[27–30]. This defect has been related to a critical role
played by these factors in establishing corticospinal pro-
jection, in which the lack of unilateral control results
from an embryonic midline abnormality involving the
corticospinal tract [28, 29]. This points to the possibility
that the EFNB2Col2KO mice might have had
Fig. 4 Impaired vascularization of ephrin-B2 (EFNB2)Col2knockout (KO) cartilage conditional mice at postnatal day P15. Representative immunohistochemical
and histochemical sections of proximal tibia, and histograms of EFNB2fl/fl (n = 7) and EFNB2Col2KO cartilage conditional (n = 7) mice at P15 for vascular
endothelial growth factor (VEGF) (a-c)), von Kossa (d-f) and tartrate resistant alkaline phosphatase (TRAP) (g-i). Sections were counterstained with
methyl green. Original magnification × 400. e Scale bar at 100 μm. f %BV/TV % bone volume/tissue volume, Tb Thickness trabecular thickness. Arrows
indicate positive staining (a, b, g, h) and trabecular thickness (d, e). Data are expressed as the mean ± standard error of the mean and P values were
determined using the Mann–Whitney U test
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abnormalities in the cortical tract even though the dele-
tion was conditional to type II collagen.
We then looked at the corticospinal tract axons of the
mice with the locomotor phenotype. To visualize the
path taken by the corticospinal tract axons, we per-
formed anterograde axon tracing experiments by inject-
ing a tracer into one side of the motor cortex and
observing the terminal projections in the spinal cord.
Compared to the control mice, there was a dramatic dif-
ference in the path of EFNB2Col2KO mouse corticospinal
axons on entering the spinal dorsal gray matter. In the
control mice, projections into the gray matter remained
confined to the contralateral gray matter, never crossing
the midline, as shown in cervical sections (Fig. 9a, c, d).
In contrast, the corticospinal tract projections of
EFNB2Col2KO mice clearly crossed over the midline into
the ipsilateral gray matter (Fig. 9b, e, f ). Indeed, in the
control mice, a high level of labeled fibers was visible in
the hemisphere contralateral to the injection site, which
is close to the midline (Fig. 9a, c), whereas few labeled fi-
bers were found in the ipsilateral hemisphere (Fig. 9d).
In contrast, the EFNB2Col2KO mice exhibited labeled fi-
bers in both hemispheres (contralateral and ipsilateral)
(Fig. 9b, e, f ), which, compared to the control mice, were
significantly fewer in the contralateral hemisphere but
more numerous in the ipsilateral hemisphere (Fig. 9g).
These neuroanatomical findings suggest that the loco-
motive phenotype was due to a neurological defect in
corticospinal projections.
Discussion
In this study, we investigated the role of EFNB2 during
endochondral bone development and its effect on adult
articular cartilage integrity, by generating cartilage-
specific EFNB2 KO mice. This model was chosen
because global deletion of EFNB2 in mice leads to em-
bryonic lethality [9, 10]. This study is the first to show
that EFNB2 is essential for postnatal skeletal growth, as
Fig. 5 Bone abnormalities of the ephrin-B2 (EFNB2)Col2knockout (KO) cartilage conditional mice. a Representative macroscopic and radiographic
EFNB2fl/fl (n = 6) and EFNB2Col2KO cartilage conditional (n = 6) mice at postnatal day P21. In the radiographs, the lower portion of EFNB2Col2KO car-
tilage conditional mice shows osteopenia (arrow) compared to EFNB2fl/fl mice. b Bone mineral density measurements of EFNB2fl/fl and EFNB2Col2KO
cartilage conditional mice at P21, 8 weeks and 1 year (n = 8–10 for each category). Micro-computed tomography (μCT) analysis of the distal femur
(c) and proximal tibia (d) (n = 8) at 8 weeks. e Representative histological sections of the proximal tibia stained with Safranin O; original magnification ×
400, scale bar at 100 μm. % BV/TVo % bone volume/tissue volume, Tb trabecular thickness. Data are expressed as mean ± standard error of the mean
and the P values were determined by Mann–Whitney U test
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Fig. 6 Osteoarthritis features in ephrin-B2 (EFNB2)Col2knockout (KO) cartilage conditional mice at 1 year old. Representative radiographs (a, b) and
histological sections (c, d) of the knee joint of EFNB2fl/fl (n = 8) and EFNB2Col2KO cartilage conditional (n = 8) mice stained with Safranin O/fast
green. Histograms show Osteoarthritis Research Society International (OARSI) scoring of the medial tibia (e) and medial condyle (f). g, h Histological
sections of the hip joint stained with Safranin O/fast green. i Hip scoring according to the modified Mankin system. *Decrease in the joint space (b).
Scale bar at 100 μm (d). Arrows indicate cartilage degradation (d, h). Histological sections at original magnification × 100. Data are expressed as the
mean ± standard error of the mean and P values were determined by Mann–Whitney U test
Fig. 7 Some ephrin-B2 (EFNB2)Col2knockout (KO) cartilage conditional mice exhibited a locomotor phenotype. EFNB2fl/fl (a, b) and about 27 % of the
EFNB2Col2KO cartilage conditional mice (c-e) demonstrated a locomotor phenotype consisting of dragging and limping as soon as they started to walk.
Additional movie files show the locomotor phenotype in more detail (see Additional file 1 (EFNB2fl/fl) and Additional file 2 (EFNB2Col2KO))
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its absence in growth plates resulted in a delay of long
bone growth including delayed primary and secondary
centers of ossification, accompanied by increased miner-
alized cartilage, delayed vascular invasion, and a reduc-
tion in TRAP-positive cells, bone density and formation
of bone trabeculae. Furthermore, the cartilage-specific
ablation of EFNB2 also led to spontaneous features of
OA associated with a decrease in joint space, cartilage
degeneration and synovial membrane alterations in both
knee and hip joints. Importantly, the latter was not re-
lated to the locomotor phenotype, as this was observed
in only 27 % of EFNB2 KO mice, and all mice had the
OA defects. Collectively, these data reinforce the hy-
pothesis that EFNB2 plays an important role in cartilage
growth and maintenance; its absence impairs endochon-
dral ossification and cartilage development and predis-
poses the joint to degeneration resembling OA.
Endochondral bone formation and growth, during
which the cartilage provides a template on which bone is
laid down, are critically dependent on chondrocyte me-
tabolism and this process involves highly organized car-
tilaginous growth plates [31–33]. Here, we demonstrated
that the delayed ossification and growth plate alteration
observed in the EFNB2Col2KO mice appears not to be
due to abnormal growth and differentiation of chondro-
cytes, as shown by the normal pattern of PCNA and type
II collagen, markers of proliferation and chondrocyte dif-
ferentiation [34]. Thus, EFNB2 seems to have no signifi-
cant influence on either the influx of resting zone cells
or on the mitogenic activity of proliferative cells in the
growth plate. However, the increased type X collagen
observed in the growth plates of EFNB2Col2KO mice
suggests an abnormal chondrocyte metabolism that
could lead to shortening of the long bones, as this colla-
gen facilitates endochondral ossification by regulating
matrix mineralization and compartmentalizing matrix
components [35, 36]. As our data showed that EFNB2
does not appear to be involved in the early stages of
chondrocyte development, but affects the hypertrophic
cells in the epiphyseal cartilage, it would be of interest to
conduct a further study in which the loss of EFNB2 is spe-
cifically restricted to the hypertrophic chondrocytes of the
growth plate cartilage, using the Col10a1 promoter.
A mechanistic explanation by which EFNB2 affects en-
dochondral ossification could be as follows. At the
chondro-ossesous junction in the growth plates, osteoclast
activity follows vascular invasion and is required for the
conversion of cartilage to bone. The communication
Fig. 8 Micro-computed tomography evaluations of the proximal femoral head of the acetabular rim angle, acetabular angle and acetabular rim
length of the ephrin-B2 (EFNB2)Col2knockout (KO) mice with a locomotor phenotype at both 8 weeks of age and 1 year. a Acetabular rim angle
(ARA), acetabular angle (AA) and acetabular rim length (ARL) of EFNB2Col2KO and EFNB2fl/fl (n = 5 and 4, respectively) at 8 weeks and b at 1 year
(n = 5 for both groups). Data are expressed as the mean ± standard error of the mean and the P values were determined by Mann–Whitney
U test
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between chondrocytes and adjacent osteoclasts is critical
for this process. Although RANKL/RANK signaling has
been implicated, additional studies have demonstrated that
there is an alternative pathway in which the insulin-like
growth factor (IGF)-1/IGF-1 receptor (IGF-1R) signaling,
a system well known to play a fundamental role during en-
dochondral bone formation [37–39], regulates EFNB2 and
its specific receptor EphB4. Hence, IGF-1 signaling
induces EFNB2/EphB4 expression in osteoblasts and
chondrocytes and EFNB2 expression in osteoclasts. This
upregulation of EFNB2/EphB4 mediates cell-cell commu-
nication necessary for IGF-1 stimulation of osteoblast,
osteoclast and chondrocyte differentiation required for en-
dochondral bone formation [40]. In addition, during the
endochondral bone formation, VEGF, among other factors,
directs adjacent inner perichondrial cells to become osteo-
blasts and form the bone collar [41]. Interestingly, Wang et
al. [42] showed that IGF-1-increased EFNB2 production
stimulates VEGF expression and vascularization. Data from
the present study demonstrate that in the absence of
EFNB2, decreased VEGF is found in the hypertrophic zone
of developing growth plate cartilage, reflecting, at least in
part, reduced vascularization in this zone.
Vascularization of the un-mineralized transverse partition
of cartilage columns is a critical step in endochondral bone
formation; chondrocytes within cartilage terminally differen-
tiate into hypertrophic chondrocytes, which produce VEGF
to stimulate angiogenesis. Such an effect in EFNB2Col2KO
mice was not surprising, as EFNB2 has been found to be
expressed by hypertrophic chondrocytes in the developing
growth plate [43], to play a crucial role in VEGF-induced
angiogenesis [44, 45], to act as a pro-angiogenic factor in
postnatal neovascularization, and to be involved in the for-
mation of the primary blood capillary [9, 10, 46–48].
Ossification begins with invasion of the calcified
hypertrophic cartilage by capillaries, but the remodeling
Fig. 9 Locomotor phenotype of some ephrin-B2 (EFNB2)Col2knockout (KO) cartilage conditional mice is related to an abnormal corticospinal tract.
a-f Brain tracing experiments to visualize the corticospinal path with biotinylated dextran amines (BDA) performed in 6-week-old EFNB2fl/fl (n = 2)
and EFNB2Col2KO cartilage conditional (n = 3) mice. Representative photomicrographs of the cervical spinal cord of EFNB2fl/fl (a, c, d) and EFNB2Col2KO
cartilage conditional mice (b, e, f) at the level of the fifth cervical vertebra. g Percentage of BDA-labeled fibers in the contralateral and ipsilateral
hemispheres. Arrowheads indicate the injection site (a, b) and labeled fibers (c-f). Scale bars at 100 μm (a, d). Data are expressed as the mean ± standard
error of the mean and the P values were determined by Mann–Whitney U test
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of bone matrix by osteoclasts is also of major import-
ance, as it results in a cavity filled with vascular channels
containing hematopoietic cells. The newly formed blood
vessels bring in osteoclast-like cells, which resorb the
mineralized cartilage [49]. The decreased number of
TRAP-positive cells and increase in mineralized cartilage
in EFNB2Col2KO probably resulted from a delay in deg-
radation of mineralized cartilage from the hypertrophic
chondrocytes themselves [50] and chondroclasts and/
or preosteclasts and osteoclasts, due to defective
vascularization [43], culminating in altered bone growth.
These findings suggest that EFNB2 acts on blood capillary
invasion into hypertrophic chondrocytes, regulating
angiogenesis at the chondro-osseous junction, thus facili-
tating endochondral bone development.
Endochondral ossification is a process that occurs
from the embryonic stages through adulthood, permit-
ting skeletal structures to be sustained during rapid bone
growth. Our findings from imaging and bone densitom-
etry showed that EFNB2Col2KO mice at P21 and 8 weeks
of age displayed reduced bone mass with lower mineral
content and trabeculae formation, resulting from the al-
tered endochondral ossification, which impacted the
long-term long bone development. However, although 1-
year-old EFNB2Col2KO mice were smaller in size and
length and had a significantly lower mineral content in
the distal femur, other features such as pelvic size and
whole body and vertebral mineral content did not differ
from controls. An explanation for the latter observation
could be that the independent, highly coordinated bone
remodeling process [51, 52], which is responsible for re-
moval and repair of damaged bone to maintain the in-
tegrity of the adult skeleton and mineral homeostasis,
could have superseded the effect of the lack of EFNB2.
Furthermore, several compensatory mechanisms that
evolve during development could also compensate for
the loss of EFNB2.
Importantly, cartilage-specific EFNB2 deletion also
leads to spontaneous OA features, in which both cartil-
age and synovial membrane display alterations. However,
the effect is not due to the abnormal gait of the
cartilage-specific EFNB2Col2KO mice, as only 27 % dem-
onstrated the locomotor phenotype, and the OA features
were present in all mutant mice. Data from this study, in
which the lack of EFNB2 led to OA, concur with and
substantiate findings demonstrating that the presence
and role of this factor in human chondrocytes positively
impact the abnormal metabolism of cartilage in OA [12].
Moreover, this study also concurs with in vivo overex-
pression of the EFNB2 specific receptor, EphB4, in ar-
ticular tissue, also demonstrating a significant decrease
in progression of OA [15]. All these data thus suggest
EFNB2 as an attractive therapeutic target in OA. As a
continuation of this study, it would be of interest to
explore whether, using this EFNB2Col2KO mouse model,
surgically induced OA, such as the destabilization of the
medial meniscus (DMM), would lead to development of
more OA features.
Of the cartilage-specific EFNB2Col2KO mice 27 % dis-
played a locomotor phenotype, which occurred as soon
as they learned to walk at P15 and continued throughout
their lifespan. One could question the low or incomplete
penetrance of the locomotor phenotype. Most explana-
tions of incomplete penetrance in genetically identical
individuals assumed differences in gene expression or
somatic genetic or epigenetic variations [53, 54]. Re-
cently, an additional model of a fundamentally different
mechanism was suggested, involving stochastic cell be-
havior in the colonization process during embryonic de-
velopment, which results in variable success in
colonization, hence allowing for incomplete penetrance
[55]. All these may arise stochastically, but once present,
they drive the phenotype so that some individuals are af-
fected while others with the same primary disease-
causing mutation are not.
We speculated that this locomotor phenotype was due
to abnormalities in hip development. However, for mice
with this phenotype, although pelvic bone and canal
width were smaller at 8 weeks, no differences were ob-
served at 1 year of age. Furthermore, there were no dif-
ferences in the acetabular parameters, suggesting that it
did not result from any developmental hip abnormality.
Yet, the walking defect in these EFNB2Col2KO mice re-
sembled that which was previously demonstrated by two
other members of the EFN family, specifically in mice
lacking EFNB3 and its specific receptor EphA4 [28, 29].
For these EFN members, the defect was demonstrated to
be related to a neurological defect occurring during the
neurodevelopment in which there is a major disruption
in the corticospinal tract, a pathway that sends messages
from the brain to the moving limbs. How can this be re-
lated to our cartilage conditional KO model? The Col2a1
Cre promoter is reported to be expressed during early
embryonic development (E9.5-11.5) on the notochord
and developing brain [56] and at later stages in all cartil-
aginous tissues. As EFNB2 also plays an important role
during neuronal development [57], in which it is found
to guide boundary and synapse formation, cell migration
and axon guidance, to name a few [4, 58–61], we there-
fore further explored the cause of the phenotype using a
tracer of the corticospinal tract. The mice had an abnor-
mal corticospinal projection pattern, with far more nu-
merous ipsilateral projections in comparison to control
mice. This finding is in line with reports on mice with
EphA4 deletion [62] and EFNB3 deletion [29], which
have similar behavioral defects. In brief, this pathway de-
pends on the crossing of neurons from one side of the
central nervous system to the other. The axons
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extending from neurons in the motor cortex of one
hemisphere of the brain typically connect to targets on
the opposite side of the spinal column. Therefore, the
left side of the brain controls limb movement on the
right side, and the right side of the brain controls limb
movement on the left side. This result demonstrates the
need for caution when the Col2a1 Cre promoter is used
in transgenic mice. However, the vascular impairment,
delayed mineralization and osteopenia displayed by the
EFNB2Col2KO mice are clearly independent of the
neurological defect found in these mice. From the
present data, it cannot yet be determined whether the
spontaneous OA phenotype observed during aging is
secondary to the observed developmental defects or
whether it is caused by an independent role of EFNB2 in
adult articular cartilage. An in vivo study with a specific
inactivation of the EFNB2 gene in adult articular cartilage
using an inducible Cre system could resolve this issue.
Conclusion
In summary, we showed for the first time that EFNB2 is
required for normal endochondral ossification, cartilage/
bone growth and development, and adult articular cartil-
age and synovial membrane preservation in vivo.
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